Literature DB >> 14605278

Treatment of secondary hyperparathyroidism by high calcium diet is associated with enhanced resistance artery relaxation in experimental renal failure.

Pasi Jolma1, Peeter Kööbi, Jarkko Kalliovalkama, Heikki Saha, Meng Fan, Jarkko Jokihaara, Eeva Moilanen, Ilkka Tikkanen, Ilkka Pörsti.   

Abstract

BACKGROUND: Vasorelaxation is impaired in renal failure (RF) and hypertension. A high calcium diet enhances vasodilatation and reduces blood pressure in experimental hypertension. Oral calcium salts are used as phosphate binders in RF. However, the effect of increased calcium intake on arterial tone in RF is unknown.
METHODS: We investigated the influence of an 8-week high calcium diet (0.3 vs 3.0%) on resistance artery tone in 5/6 nephrectomized (NTX) rats. Calcium was supplemented as carbonate salt, blood pressure measured by tail-cuff, urine collected in metabolic cages, and samples taken for blood chemistry and parathyroid hormone (PTH). Functional studies of isolated third-order branches of the mesenteric artery in vitro were performed using the Mulvany multimyograph.
RESULTS: Plasma urea was elevated 1.6-fold and systolic blood pressure by 10 mmHg after NTX, while increased calcium intake was without effect on these variables. Plasma PTH and phosphate were raised following NTX, and suppressed by high calcium diet. Vasorelaxations induced by K(+) channel agonists 11,12-epoxyeicosatrienoic acid and levcromakalim were impaired after NTX. Vasorelaxation induced by acetylcholine was also reduced following NTX, and experiments with N(G)-nitro-L-arginine methyl ester, diclofenac and charybdotoxin + apamin suggested that the K(+) channel-mediated component of endothelium-dependent relaxation was deficient after NTX. Increased calcium intake corrected all impairments of vasodilatation in NTX rats.
CONCLUSIONS: Deficient vasorelaxation via K(+) channels was normalized by high calcium diet in experimental RF. This effect was independent of the degree of renal impairment and blood pressure, but was associated with improved calcium metabolism: plasma levels of PTH and phosphate were decreased and ionized calcium was increased.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605278     DOI: 10.1093/ndt/gfg374

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  Vitamin d receptor activation mitigates the impact of uremia on endothelial function in the 5/6 nephrectomized rats.

Authors:  J Ruth Wu-Wong; William Noonan; Masaki Nakane; Kristin A Brooks; Jason A Segreti; James S Polakowski; Bryan Cox
Journal:  Int J Endocrinol       Date:  2010-02-10       Impact factor: 3.257

Review 2.  CKD-MBD: impact on management of kidney disease.

Authors:  Hiroaki Ogata; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Journal:  Clin Exp Nephrol       Date:  2007-12-21       Impact factor: 2.801

3.  Effects of switching from efavirenz to raltegravir on endothelial function, bone mineral metabolism, inflammation, and renal function: a randomized, controlled trial.

Authors:  Samir K Gupta; Deming Mi; Sharon M Moe; Michael P Dubé; Ziyue Liu
Journal:  J Acquir Immune Defic Syndr       Date:  2013-11-01       Impact factor: 3.731

4.  Effects of oxonic acid-induced hyperuricemia on mesenteric artery tone and cardiac load in experimental renal insufficiency.

Authors:  Venla Kurra; Tuija Vehmas; Arttu Eräranta; Jarkko Jokihaara; Päivi Pirttiniemi; Heikki Ruskoaho; Heikki Tokola; Onni Niemelä; Jukka Mustonen; Ilkka Pörsti
Journal:  BMC Nephrol       Date:  2015-03-27       Impact factor: 2.388

5.  Antioxidant treatment reverts increased arterial Basal tone and oxidative stress in nephrectomized (5/6) hypertensive rats.

Authors:  Rodrigo O Marañón; Claudio Joo Turoni; Maria Sofia Karbiner; Nicolas Salas; Maria Peral de Bruno
Journal:  Int J Hypertens       Date:  2013-03-13       Impact factor: 2.420

6.  Ergocalciferol improves endothelial vasodilatory and vasoconstrictor function in an in vivo model of mild uraemia.

Authors:  Gavin Dreyer; Julius Kieswich; Steven Harwood; Amrita Ahluwalia; Muhammad M Yaqoob
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.